INTRODUCTION:
The clinical laboratory is responsible for the total quality of laboratory information services from the time patientís specimen is collected to the time completed analytical result is available to the physician. The major intent of quality assurance is to identify and eliminate laboratory errors through various activities in 3 major aspects: preventive activities, assessment procedures, and corrective actions (1) (2) . The analytical errors both accuracy and precision were determined for assessment procedures. This activity consists of internal and external quality control programs. The external quality control programs have been conducted by many institute both national and international programs (3) (4) (5) (6) (7) . These offer a good assessment of the state of the art of clinical laboratory quality analysis including in clinical chemistry laboratory.
Thailand The quality improvement of clinical laboratory must be generally considered in three major areas, pre-analytical, analytical, and post-analytical processes (9) (10) (11) . All processes require high standard of technical expertise, academic background, and also a quality of management system. In Thailand, it is comparatively small number to the entire Thai population, 60 millions, with more than 3,000 medical technologists and new graduates, approximate 400 each year, from 8 state and private universities. The laboratory assistants have been allowed to perform laboratory service under the supervision of medical technologist or pathologist. Therefore, continuing education will be an essential activity for all personnel improvement.
MATERIALS AND METHOD:
Regarding to EQAC program (8) , the lyophilized control material (human or bovine serum) was in-house prepared and analyzed for 23 biochemical analytes, Albumin, Bilirubin, Calcium, Chloride, Cholesterol (Total), Cholesterol (HDL), Creatinine, Glucose, Phosphate, Potassium, Protein, Sodium, Triglyceride, Urea, Uric Acid, Alanine Transaminase, Alkaline Phosphatase, Aspartate Transaminase, Creatine Kinase, Creatine Kinase (MB), Glutamyltransferase, Lactate Dehydrogenase, and PSA, respectively. The package of lyophilized control serum is illustrated in figure 1.
The comprehensive program for EQAC consists of quality assurance training course for all new participant, a proficiency testing survey, and continuing education as summarized in figure 2.
All key personnel of participantís laboratories have been trained for understanding the concept of quality assurance before starting. A blind lyophilized control serum was monthly-cycle distributed to the participants by post together with appropriate report form. The test results were filled in the from and returned back to the organizer for evaluation within 2 weeks. 
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All returned test-report values were evaluated by a computer program. This computation of EQAC program was in-house development. The VIS was assigned as a value as calculated VI when VI lower than 400, while VIS was assigned to 400 in case of VI was 400 or higher. BIS was identical in value to the VIS, but retaining the sign of its difference from the DV. MVIS was the average of individual participant VIS. Mean MVIS was the average of all participants MVIS. The MVIS values between 0-50, 51-100, 101-150, 151-200 and higher than 200 were interpreted as very good, good, medium, low and unacceptable quality, respectively.
The proficiency testing report was enclosed in the next trial together with EQAC Newsletter.
RESULT OF QUALITY IMPROVEMENT
The number of participant in EQAC program was obviously increased from 45 laboratories in 1986 to 324 in 1999 as presented in figure 3 . It was rapid growth in number during 1986-1989 and 1992-1995 . The distribution of 324 laboratories was 59% of general hospital and community health hospital, 29% of private hospital including polyclinics, and 12% of the others from the university hospitals (2%), military hospitals (4%), state enterprise service hospitals (2%), and Bangkok Metropolitan hospitals (4%). To date, 144 trials for proficiency testing of 23 general chemistry tests were continuously performed by this program. The average MVIS of participant laboratory was dramatically decreased from the value of 120 to 82 in the first 2 years of EQAC program. The later was maintained at 90-93 as shown in Figure 4 . About 60% of participants had good MVIS of 100 which denoted approved quality while 31% were at MVIS of 101-150 (medium quality) and 9% were unacceptable quality MVIS. 
NEXT STEP OF QUALITY IMPROVEMENT:
Recently, the Office of Laboratory Standards was founded by Ministry of Public Health for the promotion of quality service in laboratory medicine. This office decided to use ISO/IEC Guide 25 for laboratory standardization. Officially, this guide has been managed by the Thailand Industrial Standard Institute (TISI) which is one of 16 member countries of the Asian-Pacific Laboratory Accreditation Co-operation (APLAC). The APLAC member consists of Australia, Brunei, Canada, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Nepal, New Zealand, Papua New Guinea, Philippines, Singapore, Taiwan, Thailand, USA and Vietnam.
The proficiency testing is one of the essential technical requirement in ISO/IEC Guide 25 (12) . With very high experience in management of proficiency testing program, the EQAC can step forward to be a certified body for this particular activity.
The academic institute in Thailand also internationally participated and operated for quality improvement promotion. the EQAC program was assigned to be WHO collaboration for the quality assurance training program. Two or more training requests from Asian countries such as Sri Lanka, Nepal, Phutan, Bangladesh, Burma and PDR Korea was submitted to EQAC each year. Recently, more than 20 participants from those countries had been trained for management of quality assessment for clinical chemistry laboratory. In early 1999, the First Colloquium on Standardization of Laboratory Medicine in Asia was held in University of Indonesia under the co-operation with The Japan Society for the Promotion of Science (JSPS) to initiate laboratory standardization between Asian countries including Thailand. This seminar was prepared for sharing the experience and addressing state of the art of quality assurance in clinical chemistry laboratory among the participants, developing a guideline for good laboratory practice, and planing a multi-lateral co-operation system of Asian regional body responsible for clinical laboratory quality standardization in the next millennium.
CONCLUSION:
This EQAC managed the proficiency testing for 12 years without interruption so that it has been recognized as a major institute for quality improvement of clinical chemistry laboratory in Thailand. Apart from first TEQAS supported by WHO, the EQAC program provided not only the proficiency testing but also education and consultation by mean of national and international training courses, and monthly published Newsletter. EQAC program can be classified as second generation of quality improvement in Thailand. However, several community hospital laboratories need to improve service quality by upgrading their knowledge and skill. To boost up the quality service, it needs to have the next generation quality improvement which has closed interaction with participant in quality problem solving. ISO/IEC Guide 25 is promising system for this activity. Due to the capability of university based EQAC, this program has been proven not only to be certified proficiency testing body in Thailand but also to be international training center for quality assurance. 
